HB 1260: Relating to the disclosure of financial interests by and the regulation of advertising by health care practitioners who promote or facilitate the sale of drugs to consumers; providing administrative and civil penalties.
Latest action, Nov. 20, 2026: Filed
Number
HB 1260, bill, filed in the House
Session
90th Legislature Regular Session
Standing
Introduced, Nov. 20, 2026
Subjects
Business & Commerce; Business & Commerce--General; Civil Remedies & Liabilities; Health Care Providers; ADVERTISING; MEDICINE & PRESCRIPTION DRUGS; PHARMACIES & PHARMACISTS; TELEMEDICINE; HEALTH PROFESSIONS COUNCIL
The bill’s record: its number and title, where it stands, its sponsors, every action in its legislature’s words, every version, the roll calls on it, and every change the site recorded, with LegiScan’s license.